Nuvrumetinib
Nuvrumetinib (PAS-004) is a macrocyclic MEK inhibitor. Nuvrumetinib functionally inhibits MEK1/2, thereby suppressing pERK in tumors. Nuvrumetinib inhibits the proliferation of NRAS-mutant cancer cells. Nuvrumetinib can be used in studies related to NRASG12C-mutant solid tumors, neurofibromatosis type 1 (NF1), RASopathies and laminopathies.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3079099-31-0
- Formel: C19H18F3IN2O5S
- Molecular Weight:570.32
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle MEK Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
MEK1 |
MEK2 |
In Vitro
Chemical Information
-
CAS. Nr. 3079099-31-0
-
Molecular Weight 570.32
-
Formel C19H18F3IN2O5S
-
SMILES
O=S1(C2(C[C@H]([C@H](COC3=CC(F)=C(F)C(NC4=C(C=C(C=C4)I)F)=C3N1)O)O)CC2)=O
-
Synonyms
PAS-004
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)